- Investing Ideas
- /
- Global Pharmaceuticals & Biotech High Insider Buying
Global Pharmaceuticals & Biotech High Insider Buying
Results
162
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
162 companies
Patrys
Market Cap: AU$10.9m
Develops antibody technologies for the treatment of cancer and NETosis-driven inflammatory diseases.
PAB
AU$0.032
7D
-13.5%
1Y
-46.7%
OncoZenge
Market Cap: SEK 67.4m
A pharmaceutical company, engages in the development of treatment for pain relief in patients suffering from oral pain caused by radiation therapy and chemotherapy for cancer in Sweden.
ONCOZ
SEK 5.33
7D
-5.3%
1Y
15.9%
BetterLife Pharma
Market Cap: US$6.9m
A biotechnology company, primarily focuses on developing compounds for the treatment of mental disorders in Canada.
BETR.F
US$0.046
7D
16.8%
1Y
-49.8%
Marvel Biosciences
Market Cap: CA$9.3m
A biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada.
MRVL
CA$0.16
7D
-5.9%
1Y
-3.0%
Christina Lake Cannabis
Market Cap: CA$8.7m
A license cannabis producer, engages in the research and development, cultivation, processing, production, and sale of cannabis in Canada.
CLC
CA$0.03
7D
-14.3%
1Y
0%
Delivra Health Brands
Market Cap: CA$8.4m
Through its subsidiaries, engages in the health and wellness consumer packaged goods business worldwide.
DHB
CA$0.27
7D
-3.6%
1Y
54.3%
Silo Pharma
Market Cap: US$6.0m
Silo Pharma Inc. operates as a developmental stage biopharmaceutical company.
SILO
US$0.45
7D
15.3%
1Y
-55.0%
Salarius Pharmaceuticals
Market Cap: US$5.4m
Focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology (IMP3ACT) platform that reduces the complexity of drug development and manufacturing.
SLRX
US$0.93
7D
6.3%
1Y
-95.7%
CTT Pharmaceutical Holdings
Market Cap: US$4.4m
Engages in the development of oral drug delivery systems for pain management and treatment.
CTTH
US$0.074
7D
48.8%
1Y
6.4%
Rua Bioscience
Market Cap: NZ$6.8m
Engages in the research, development, and sale of pharmaceutical products in New Zealand and internationally.
RUA
NZ$0.028
7D
3.7%
1Y
-6.7%
Prostatype Genomics
Market Cap: SEK 36.6m
Prostatype Genomics AB manufactures, markets, and sells prognostic gene tests.
PROGEN
SEK 0.62
7D
9.2%
1Y
-91.9%
AdAlta
Market Cap: AU$5.7m
A clinical-stage biotechnology company, discovers and develops protein and cell-based therapeutics by its i-body platform in Australia.
1AD
AU$0.003
7D
-25.0%
1Y
-83.3%
Rakovina Therapeutics
Market Cap: CA$2.7m
A biopharmaceutical research company, engages in the research and development of cancer treatments based on novel series of small-molecule DNA-damage response targets.
RKV
CA$0.13
7D
8.3%
1Y
-83.8%
Algernon Health
Market Cap: CA$2.7m
Operates as a clinical stage pharmaceutical development company in Canada and Australia.
AGN
CA$0.08
7D
0%
1Y
0%
1933 Industries
Market Cap: CA$2.5m
Engages in the cultivation, extraction, and production of cannabis products in the United States.
TGIF
CA$0.005
7D
-50.0%
1Y
-50.0%
Bespoke Extracts
Market Cap: US$1.5m
Together with its subsidiary, Bespoke Extracts Colorado, LLC, produces and sells pre-rolled marijuana cigarettes in the United States.
BSPK
US$0.13
7D
-28.9%
1Y
20.2%
PharmaLundensis
Market Cap: SEK 15.3m
PharmaLundensis AB operates as a pharmaceutical company.
PHAL
SEK 0.36
7D
0%
1Y
-44.6%
Jolt Health
Market Cap: CA$1.1m
Operates as a licensee of technologies relating to substances and pharmaceutical grade therapeutics in Canada.
JOLT
CA$0.085
7D
0%
1Y
-15.0%